Altamira Therapeutics Ltd.: xbrl:AccrualsClassifiedAsCurrent

Value	`{"amount": 901923, "currency": "USD"}`
Period	(as of 2025-06-30)
Status	current
Entity	Altamira Therapeutics Ltd.

Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-25-082071
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/184d06fe-a45e-4a84-8d43-99013dbcaa49

History

no predecessors — first report